col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


113 Ergebisse       Seite 1

 [1] 
Springer-Verlag: Annals of Hematology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2026―Jan―21 Prevention, diagnosis and management of community acquired respiratory virus infections including COVID-19 in patients with cancer: 2025 updated evidence-based guideline of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO) Nicola Giesen, Sibylle C. Mellinghoff, Elham Khatamzas, Felix Korell, Marcus Hentrich, Hermann Einsele, et al. (+14)
2 [GO] 2025―Okt―11 Global burden of acute lymphoblastic leukemia following the COVID-19 pandemic Hongxuan Fan, Yafen Yang, Yanyan Lu, Jiahui Li, Zhuolin Huang, Zhaoyu Ren, Boda Zhou
3 [GO] 2025―Sep―20 Treatment persistence and overall survival in myelofibrosis treated with ruxolitinib were not affected by the covid-19 pandemic, despite the reduced starting dose: Analysis of AIFA registries Massimo Breccia, Simone Celant, Francesca Palandri, Francesco Passamonti, Pier Paolo Olimpieri, Valentina Summa, et al. (+7)
4 [GO] 2025―Jun―04 SARS-CoV-2 infection does not affect the outcome of patients with relapsed/refractory large B-cell lymphoma treated with CAR T-cell therapy Marianna Gentilini, Beatrice Casadei, Cinzia Pellegrini, Lisa Argnani, Gabriele Gugliotta, Matteo Carella, et al. (+11)
5 [GO] 2025―Apr―22 Correction to: Anti CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the RFolSTOP multicentre Italian study Alessia Castellino, Lorenzo Comba, Laura Bertolotti, Carola Boccomini, Michele Clerico, Paolo Nicoli, et al. (+19)
6 [GO] 2025―Mrz―12 Anti-CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the R-FolSTOP multicentre Italian study Alessia Castellino, Lorenzo Comba, Laura Bertolotti, Carola Boccomini, Michele Clerico, Paolo Nicoli, et al. (+19)
7 [GO] 2024―Dez―11 COVID-19 outcomes among patients with sickle cell disease or sickle cell trait compared to the general population: a systematic review and meta-analyses Yachar Dawudi, Loris Azoyan, Matthieu Bonjour, Olivier Steichen
8 [GO] 2024―Nov―05 COVID-19 infection in children with blood cancer: A systematic review Saad Alhumaid, Khalid Al Noaim, Anwar A. Almuslim, Jamela A. Turkistani, Zainab Sabri Alqurini, Abdullah Mohammed Alshakhs, et al. (+26)
9 [GO] 2024―Okt―23 Aplastic Anemia in the light of the COVID-19 pandemic: infection, vaccination, and pathophysiologic mechanisms Nelson Luis Cahuapaza-Gutierrez
10 [GO] 2024―Sep―14 Impacts of the COVID-19 pandemic on pediatric and adult patients with hemophilia Shuxia Zhang, Bangxiang Xie, Yanfang Lin, Chunrong Chen, Shu Yang, Shujuan Xu, et al. (+4)
11 [GO] 2024―Aug―31 Cold case: COVID-19-triggered type 1 cryoglobulinemia L.A.J. van Gils, M.F. Corsten, C.A. Koelman, R.J. Bosma, R. Fijnheer, A.H.L. Mulder, J.C. Regelink
12 [GO] 2024―Jul―16 Correction to: SARS-CoV-2 infection-induced immune thrombocytopenia: a systematic review of current reports Ryohei Ono, Izumi Kitagawa
13 [GO] 2024―Jul―15 Vaccine challenges in CLL: a comprehensive exploration of efficacy of SARS-CoV-2 immunization for patients with chronic lymphocytic leukemia Christina-Nefeli Kontandreopoulou, Elena E. Solomou, Epaminondas Kolorizos, Panagiotis T. Diamantopoulos
14 [GO] 2024―Apr―23 SARS-CoV-2 infection-induced immune thrombocytopenia: a systematic review of current reports Ryohei Ono, Izumi Kitagawa
15 [GO] 2024―Apr―22 Multi-center study of COVID-19 infection in elderly patients with lymphoma: on behalf of Jiangsu Cooperative Lymphoma Group (JCLG) Huayuan Zhu, Xiao Lu, Xiaoping Zhang, Haiying Hua, Jie Zhang, Yuqing Miao, et al. (+23)
16 [GO] 2024―Apr―18 COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort study Sophie Thau, Christian Bjørn Poulsen, Christian Brieghel, Morten Kranker Larsen, Lothar Wiese, Xiaohui Chen Nielsen, Lars Møller Pedersen
17 [GO] 2024―Mrz―25 The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: A nationally representative, prospective, multicentre, observational study Haixia Fu, Xuan Cai, Lijuan Cui, Weixia Nong, Wenqian Li, Heng Mei, et al. (+78)
18 [GO] 2024―Mrz―04 Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies Patrick Reimann, Verena Petzer, Axel Mündlein, Bernd Hartmann, Luciano Severgnini, Alex Winkler, et al. (+16)
19 [GO] 2024―Feb―21 Clinical characteristics and outcomes of allogeneic hematopoietic stem cell transplantation recipients with coronavirus disease 2019 caused by the Omicron variant: a prospective, observational cohort study Shuang Fan, Xiaodong Mo, Xiaohui Zhang, LanPing Xu, Yu Wang, Chenhua Yan, et al. (+11)
20 [GO] 2024―Feb―13 Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers Rasoul Ebrahimi, Fatemeh Nasri, Tahereh Kalantari
21 [GO] 2024―Jan―03 Acute liver injury after SARS-CoV-2 vaccination and luspatercept administration in a patient with β-thalassemia Simona Leoni, Rayan Bou-Fakhredin, Francesca Granata, Elena Cassinerio, Marco Maggioni, Anna Ludovica Fracanzani, et al. (+2)
22 [GO] 2023―Dez―28 Clinical characteristics of SARS-CoV-2 Omicron variant infection in children with acute leukemia Pengli Huang, Henghui Chang, Ruidong Zhang, Ying Wu, Peijing Qi, Yaguang Peng, et al. (+2)
23 [GO] 2023―Dez―14 Effectiveness of tixagevimab/cilgavimab in patients with hematological malignancies as a pre-exposure prophylaxis to prevent severe COVID-19: a Czech retrospective multicenter study Ivo Demel, David Skopal, Eliška Šafránková, Petra Rozsívalová, Pavel Jindra, Jiří Šrámek, et al. (+12)
24 [GO] 2023―Nov―30 COVID-19 vaccine-induced immune thrombotic thrombocytopenia: pathophysiology and diagnosis Akbar Dorgalaleh, Ashkan Shabannezhad, Saeed Hassani
25 [GO] 2023―Nov―27 Warm autoimmune hemolytic anemia associated with SARS-CoV-2 infection responsive to eculizumab Yuemin Gong, Xinyu Zhang, Xiaoyu Chen, Hui Yang, Yawen Zhang, Guangsheng He, Jianyong Li
26 [GO] 2023―Nov―11 Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study Odil Giladi, Gianmarco Bagnato, Marianna Gentilini, Shai Shimony, Oren Pasvolsky, Tamar Berger, et al. (+8)
27 [GO] 2023―Okt―02 Clinical outcome of breakthrough COVID-19 in multiple myeloma patients after three or more anti-SARS-CoV-2 vaccine doses: a single center analysis of 64 cases Nicola Sgherza, Paola Curci, Rita Rizzi, Olga Battisti, Alberto Perfetto, Stefania Weigl, et al. (+4)
28 [GO] 2023―Aug―15 Association between ABO blood group/genotype and COVID-19 in a Japanese population Tatsuya Kusumoto, Shotaro Chubachi, Ho Namkoong, Hiromu Tanaka, Ho Lee, Shuhei Azekawa, et al. (+34)
29 [GO] 2023―Aug―14 Patients with chronic myeloid leukemia and coronavirus disease 2019 in the Omicron era Feiyang Qi, Mei Bao, Hanlin Gao, Xiaoshuai Zhang, Shasha Zhao, Chenglei Wang, et al. (+2)
30 [GO] 2023―Jul―13 Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region Alessia Sticchi Damiani, Antonella Zizza, Federico Banchelli, Maddalena Gigante, Maria Lucia De Feo, Angelo Ostuni, et al. (+5)
31 [GO] 2023―Jul―12 Characteristics and outcomes of COVID-19 in patients with plasma cell dyscrasias during the first Omicron wave in Beijing since December 2022: a retrospective study at a National Clinical Research Center for Hematologic Disease Qing He, Xuelin Dou, Yang Liu, Lei Wen, Fengrong Wang, Nan Peng, et al. (+7)
32 [GO] 2023―Jul―05 COVID-19 and β-thalassemia: in lieu of evidence and vague nexus Hayder M. Al-Kuraishy, Mohamed H. Mazhar Ashour, Hebatallah M. Saad, Gaber El-Saber Batiha
33 [GO] 2023―Jun―09 COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma Victoria R. Nachar, Anthony J. Perissinotti, Bernard L. Marini, Yasmin H. Karimi, Tycel J. Phillips
34 [GO] 2023―Apr―19 Status of major hemostatic components in the setting of COVID-19: the effect on endothelium, platelets, coagulation factors, fibrinolytic system, and complement Mohammad Sayyadi, Saeed Hassani, Mahmood Shams, Akbar Dorgalaleh
35 [GO] 2023―Apr―12 Anti-CD20 antibodies and bendamustine attenuate humoral immunity to COVID-19 vaccination in patients with B-cell non-Hodgkin lymphoma Takashi Ishio, Shihori Tsukamoto, Emi Yokoyama, Koh Izumiyama, Makoto Saito, Haruna Muraki, et al. (+4)
36 [GO] 2023―Apr―11 Gut microbiome alterations in patients with COVID-19-related coagulopathy Youli Chen, Xin Li, Cheng Yu, Erchuan Wang, Chang Luo, Yu Jin, et al. (+12)
37 [GO] 2023―Mrz―26 G6PD deficiency-does it alter the course of COVID-19 infections? Tsz Yuen Au, Oskar Wojciech Wiśniewski, Shamiram Benjamin, Tadeusz Kubicki, Dominik Dytfeld, Lidia Gil
38 [GO] 2023―Mrz―25 Real-life experience of secondary prophylaxis with DOACs in splanchnic venous thrombosis during COVID-19 pandemic Luca Guarnera, Elisa Buzzatti, Fabrizio Bonanni, Giovangiacinto Paterno, Antonella Riccitelli, Vittorio Forte, et al. (+2)
39 [GO] 2023―Mrz―02 Humoral response to mRNA-based COVID-19 vaccine and booster effect of a third dose in patients with mature T cell and NK-cell neoplasms Mirei Kobayashi, Akio Mori, Masahiro Onozawa, Shihori Tsukamoto, Hajime Senjo, Takashi Ishio, et al. (+8)
40 [GO] 2023―Feb―27 COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group Martin Šimkovič, Peter Turcsányi, Martin Špaček, Jana Mihályová, Pavlína Ryznerová, Mária Maco, et al. (+18)
41 [GO] 2023―Feb―16 Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination Jeremy W. Jacobs, Garrett S. Booth, Brian D. Adkins
42 [GO] 2022―Dez―10 BRAF inhibitor treatment of classical hairy cell leukemia allows successful vaccination against SARS-CoV-2 Judith Konrat, Wiebke Rösler, Michael Roiss, Fabienne Meier-Abt, Corinne C. Widmer, Stefan Balabanov, et al. (+2)
43 [GO] 2022―Nov―24 Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain Ariana Ortuzar, María Laura Fox, Juan Antonio Vera, Álvaro Lorenzo Vizcaya, Alberto Marín Sánchez, Inmaculada Llopis Calatayud, et al. (+26)
44 [GO] 2022―Nov―18 CD19 CAR T-cell infusion during severe COVID-19 acute respiratory distress syndrome in large B-cell lymphoma Nina Buchtele, Philipp Wohlfarth, Thomas Staudinger, Peter Schellongowski, Ludwig Traby, Matthias Vossen, et al. (+5)
45 [GO] 2022―Nov―12 New-onset Evans syndrome in a patient with SLE post SARS-CoV2 mRNA vaccination Timothy Y. M. Ng, Winnie Z. Y. Teo, Terence Y. M. Ng, Gim Gee Teng
46 [GO] 2022―Okt―22 Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection Panagiotis T. Diamantopoulos, Christina-Nefeli Kontandreopoulou, Christos Stafylidis, Dimitra Vlachopoulou, Nefeli Giannakopoulou, Maria Vardaka, et al. (+7)
47 [GO] 2022―Aug―26 Amyloidosis and COVID-19: experience from an amyloid program in Canada Ellen Lewis, Nowell Fine, Robert J. H. Miller, Christopher Hahn, Sameer Chhibber, Etienne Mahe, et al. (+6)
48 [GO] 2022―Aug―02 B-cell-guided strategy for SARS-CoV2 vaccination after autologous stem cell transplantation for B-cell lymphoma - a case report Ben-Niklas Baermann, Paul Jäger, Guido Kobbe
49 [GO] 2022―Jul―14 An association between a positive direct antiglobulin test and HLA-DR12 in COVID-19 Hideaki Matsuura, Sumie Fujii, Yusuke Matsui, Yukari Sugiura, Hidehiko Akiyama, Yasuo Miura
50 [GO] 2022―Jul―14 Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies Ferenc Magyari, László Imre Pinczés, Edit Páyer, Katalin Farkas, Szilvia Ujfalusi, Ágnes Diószegi, et al. (+6)
51 [GO] 2022―Jul―08 Hemolytic anemia in COVID-19 Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Ajeet Kaushik, Małgorzata Kujawska, Gaber El-Saber Batiha
52 [GO] 2022―Jul―02 Venous thromboembolism after COVID-19 mRNA vaccination Philip Murphy
53 [GO] 2022―Jul―02 Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients José Luis Piñana, Pablo Rodríguez-Belenguer, Dolores Caballero, Rodrigo Martino, Lucia Lopez-Corral, María-José Terol, et al. (+26)
54 [GO] 2022―Jun―20 Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) Daniele Zama, Francesco Baccelli, Antonella Colombini, Amalia Contino, Elisabetta Calore, Maria Grazia Petris, et al. (+24)
55 [GO] 2022―Mai―24 SARS-CoV-2 PrEP complicates antibody testing after vaccination: a call for awareness Malte B. Monin, Benjamin Marx, Lisa Meffert, Christoph Boesecke, Jürgen K. Rockstroh, Christian P. Strassburg, et al. (+2)
56 [GO] 2022―Mai―21 Definition of factors associated with negative antibody response after COVID-19 vaccination in patients with hematological diseases Jil Rotterdam, Margot Thiaucourt, Christel Weiss, Juliana Schwaab, Andreas Reiter, Sebastian Kreil, et al. (+11)
57 [GO] 2022―Apr―11 COVID-19: impact of vaccination in myeloma patients E. Hoornaert, F. Dachy, A. Hansenne, S. Bailly, A. van Maanen, D. Gruson, M-C. Vekemans
58 [GO] 2022―Apr―07 Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies Ryutaro Taenaka, Teppei Obara, Kentaro Kohno, Kenichi Aoki, Ryosuke Ogawa
59 [GO] 2022―Mrz―11 Higher ferritin levels in COVID-19 patients are associated with hyperinflammation, worse prognosis, and more bacterial infections without pronounced features of hemophagocytosis Marko Lucijanic, Martina Demaria, Jelena Gnjidic, Zrinka Rob, Dora Filipovic, Toni Penovic, et al. (+9)
60 [GO] 2022―Feb―04 No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey Eriko Hamada, Kazuya Sakai, Shinya Yamada, Masayuki Kubo, Masaki Hayakawa, Masanori Matsumoto
61 [GO] 2022―Jan―27 Deep venous thrombosis and pulmonary embolism after COVID-19 mRNA vaccination Ali Atoui, Kawthar Jarrah, Layal Al Mahmasani, Rayan Bou-Fakhredin, Ali T. Taher
62 [GO] 2021―Dez―04 Hemophagocytosis, hyper-inflammatory responses, and multiple organ damages in COVID-19-associated hyperferritinemia Guiying Dong, Jianbo Yu, Weibo Gao, Wei Guo, Jihong Zhu, Tianbing Wang
63 [GO] 2021―Okt―18 ChAdOx1 nCov-19 vaccine-induced thrombotic thrombocytopenic purpura successfully treated with plasmapheresis Yen-Ching Wang, Tsung-Chih Chen, Chieh-Lin Jerry Teng, Cheng-Han Wu
64 [GO] 2021―Okt―13 Autologous hematopoietic stem cell transplantation with concomitant SARS-CoV-2 infection Hanna A. Knaus, W. Rabitsch, N. Buchtele, J. Cserna, P. Wohlfarth
65 [GO] 2021―Okt―01 Vincristine therapy for severe and refractory immune thrombocytopenia following COVID-19 vaccination Kei Saito, Satoshi Ichikawa, Shunsuke Hatta, Yuna Katsuoka, Hideo Harigae, Tohru Izumi
66 [GO] 2021―Sep―24 Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India Anshul Gupta, Nihar Desai, Priyanka Chauhan, Soniya Nityanand, Zia Hashim, Mansi Gupta
67 [GO] 2021―Sep―22 Impact of rituximab on COVID-19 outcomes Hannah Levavi, Guido Lancman, Janice Gabrilove
68 [GO] 2021―Sep―17 Mortality by COVID-19 in adults with acute myeloid leukemia: a survey with hematologists in Brazil Evandro M. Fagundes, Naira N. Neto, Lorena M. Caldas, Jordana R. Aragão, Ana Beatriz F. Gloria, Leonardo G. Leite, et al. (+5)
69 [GO] 2021―Sep―13 Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue Robin Arcani, Julien Colle, Raphaël Cauchois, Marie Koubi, Pierre-André Jarrot, Rodolphe Jean, et al. (+8)
70 [GO] 2021―Aug―22 Association of blood type A with increased risk of severe COVID-19 in healthcare workers Niraj N. Mahajan, Rahul K. Gajbhiye, Periyasamy Kuppusamy, Shubhada Bahirat, Pradip D. Lokhande
71 [GO] 2021―Jul―26 Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience Marta Krejci, Ludek Pour, Zdenek Adam, Viera Sandecka, Martin Stork, Sabina Sevcikova, et al. (+3)
72 [GO] 2021―Jul―26 Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine Johannes Ruhe, Ulf Schnetzke, Karim Kentouche, Florian Prims, Michael Baier, Konstantin Herfurth, et al. (+4)
73 [GO] 2021―Jul―24 Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis Giovanni Caocci, Olga Mulas, Daniela Mantovani, Alessandro Costa, Andrea Galizia, Luca Barabino, et al. (+3)
74 [GO] 2021―Mai―25 Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals Can Boğa, Süheyl Asma, Göksel Leblebisatan, Nazan Şen, Anıl Tombak, Yusuf Ziya Demiroğlu, et al. (+8)
75 [GO] 2021―Mrz―08 Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies Yujia Zhang, Rachael Garner, Sana Salehi, Marianna La Rocca, Dominique Duncan
76 [GO] 2021―Feb―19 Severe warm autoimmune hemolytic anemia in COVID-19 managed with least incompatible RBC product and glucocorticoids Tien-Chan Hsieh, Oleg Sostin
77 [GO] 2021―Feb―02 Management of chronic patients during the COVID-19 pandemic: the experience of a referral center for rare hematological disorders in the hardest-hit region in Italy Irene Motta, Alessia Marcon, Maria Domenica Carrabba, Elena Cassinerio, Margherita Migone De Amicis, Adriana Branchi, et al. (+5)
78 [GO] 2021―Feb―01 Hematologic changes predict clinical outcome in recovered patients with COVID-19 Jian Mao, Rong Dai, Rui-Chan Du, Yan Zhu, Li-Ping Shui, Xiao-Hua Luo
79 [GO] 2021―Feb―01 COVID-19 pandemic and transfusion medicine: the worldwide challenge and its implications Layal Al Mahmasani, Mohammad Hassan Hodroj, Antoine Finianos, Ali Taher
80 [GO] 2021―Jan―18 HSV1 viremia with fulminant hepatitis as opportunistic sequela in severe COVID-19 Luca Roncati, Antonio Manenti, Luca Fabbiani, Claudia Malagoli, Vincenzo Nasillo, Beatrice Lusenti, et al. (+6)
81 [GO] 2021―Jan―07 Hematologic disorders associated with COVID-19: a review Mandeep Singh Rahi, Vishal Jindal, Sandra-Patrucco Reyes, Kulothungan Gunasekaran, Ruby Gupta, Ishmael Jaiyesimi
82 [GO] 2020―Nov―17 Questioning the association between ABO type and outcomes in patients with COVID-19 Jori E. May, Gerald McGwin, Radhika Gangaraju, Rita Paschal, Kaci Weaver, Jose L. O. Lima, Marisa B. Marques
83 [GO] 2020―Nov―13 Blood and platelet transfusion from a donor with presymptomatic Covid-19 Konstantinos Liapis, Menelaos Papoutselis, Georgios Vrachiolias, Christina Misidou, Emmanouil Spanoudakis, Zoe Bezirgiannidou, et al. (+3)
84 [GO] 2020―Nov―10 Hemolytic crisis in a patient treated with eculizumab for paroxysmal nocturnal hemoglobinuria possibly triggered by SARS-CoV-2 (COVID-19): a case report Hannah Schüller, Franziska Klein, Michael Lübbert, Eric Peter Prager
85 [GO] 2020―Nov―07 COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry Maria Madeleine Rüthrich, C. Giessen-Jung, S. Borgmann, A. Y. Classen, S. Dolff, B. Grüner, et al. (+15)
86 [GO] 2020―Nov―06 Plasma hemoglobin in COVID-19: authors’ reply Guido Lancman, Bridget K. Marcellino, Santiago Thibaud, Kevin Troy
87 [GO] 2020―Okt―20 Characteristics of coagulation alteration in patients with COVID-19 Hong-chun Luo, Cheng-yan You, Si-wei Lu, Yue-qiang Fu
88 [GO] 2020―Okt―07 Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies Alessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, Caterina Musolino
89 [GO] 2020―Sep―24 Elevated plasma hemoglobin in COVID-19-related illnesses: a critical appraisal Nishant R. Tiwari, Nagnath K. Redewad, Apurva A. Ketkar, Vivek R. Sharma
90 [GO] 2020―Sep―12 Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection Abdulrahman A. Algassim, Assem A. Elghazaly, Abdulrahman S. Alnahdi, Owais M. Mohammed-Rahim, Abdulaziz G. Alanazi, Nawaf A. Aldhuwayhi, et al. (+5)
91 [GO] 2020―Aug―28 High density of IgG4-secreting plasma cells in the fibrotic tissue from a surgically resected tracheal ring impaired by complex subglottic stenosis post-tracheostomy as immune expression of a Th2 response due to severe COVID-19 Luca Roncati, Giuliano Bergonzini, Beatrice Lusenti, Vincenzo Nasillo, Ambra Paolini, Giuliana Zanelli, Stefania Corrado
92 [GO] 2020―Aug―17 Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience Ahmad Hanif, Sumera Khan, Nikhitha Mantri, Sana Hanif, Muhamed Saleh, Yamini Alla, et al. (+6)
93 [GO] 2020―Aug―01 Coombs-negative hemolytic anemia and elevated plasma hemoglobin levels in COVID-19 Guido Lancman, Bridget K. Marcellino, Santiago Thibaud, Kevin Troy
94 [GO] 2020―Jul―18 COVID-19 infection in patients with multiple myeloma: a German-Chinese experience from Würzburg and Wuhan Xiang Zhou, Tao Bai, Katharina Meckel, Jun Song, Yu Jin, K. Martin Kortüm, et al. (+3)
95 [GO] 2020―Jul―18 Thrombocytopenia in COVID-19: pathophysiology matters Eleni Gavriilaki, Ioanna Sakellari, Maria Gavriilaki, Achilles Anagnostopoulos
96 [GO] 2020―Jul―12 Blood type and outcomes in patients with COVID-19 Christopher A. Latz, Charles DeCarlo, Laura Boitano, C. Y. Maximilian Png, Rushad Patell, Mark F. Conrad, et al. (+2)
97 [GO] 2020―Jun―29 Measures for preventing nosocomial infection with SARS-CoV-2 in hematology departments Yingying Wang, Jingfeng Li, Li Liu, Jianfang Li, Xiaoyan Liu, Jing He, et al. (+4)
98 [GO] 2020―Jun―26 SARS-CoV-2-associated cold agglutinin disease: a report of two cases Tessa Huscenot, Joris Galland, Margot Ouvrat, Mathias Rossignol, Stéphane Mouly, Damien Sène
99 [GO] 2020―Jun―25 IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection Carolina Villegas, María Poza, Paloma Talayero, José Manuel Caro Teller, Denis Zafra, Cristina Garcia, et al. (+9)
100 [GO] 2020―Jun―24 COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure Monia Marchetti
101 [GO] 2020―Jun―23 COVID-19, impact on myeloma patients Inès Dufour, Juliette Raedemaeker, Fabio Andreozzi, Géraldine Verstraete, Sarah Bailly, Michel Delforge, et al. (+13)
102 [GO] 2020―Jun―16 COVID-19 infection associated with autoimmune hemolytic anemia Antoine Capes, Sarah Bailly, Philippe Hantson, Ludovic Gerard, Pierre-François Laterre
103 [GO] 2020―Jun―13 COVID-19 presenting as neutropenic fever Hunter C. Spencer, Riana Wurzburger
104 [GO] 2020―Jun―13 SARS-CoV-2 impact in a community-based hematological ward in an Italian Red Zone Giuseppe Visani, Martina Chiarucci, Barbara Guiducci, Maria Capalbo, Alessandro Isidori
105 [GO] 2020―Jun―12 SARS-CoV-2 infection in children with febrile neutropenia Victoria Flores, Raquel Miranda, Laura Merino, Carmen González, Cristina Serrano, Moises Solano, et al. (+6)
106 [GO] 2020―Jun―11 Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection Michele Merli, Walter Ageno, Fausto Sessa, Marco Salvini, Domenica Caramazza, Barbara Mora, et al. (+4)
107 [GO] 2020―Jun―04 Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy-a case report Zhiliang Hu, Wei Chen, Wenyan Liang, Chuanjun Xu, Wenkui Sun, Yongxiang Yi
108 [GO] 2020―Jun―03 Hematological findings in coronavirus disease 2019: indications of progression of disease Xiaoqing Liu, Run Zhang, Guangsheng He
109 [GO] 2020―Mai―27 Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19 Nil Albiol, Rahinatu Awol, Rodrigo Martino
110 [GO] 2020―Mai―24 Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease Luca Roncati, Beatrice Lusenti, Vincenzo Nasillo, Antonio Manenti
111 [GO] 2020―Mai―14 Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)? Giovanni Caocci, Giorgio La Nasa
112 [GO] 2020―Mai―08 Signals of Th2 immune response from COVID-19 patients requiring intensive care Luca Roncati, Vincenzo Nasillo, Beatrice Lusenti, Giovanni Riva
113 [GO] 2020―Apr―15 Mechanism of thrombocytopenia in COVID-19 patients Panyang Xu, Qi Zhou, Jiancheng Xu
 [1] 

113 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.016 sec